NOSOTROS:
Welcome | Grunenthal Grünenthal uses its own and third-party cookies to improve the browsing experience, offer personalized content and improve its services. We use analytics scripts which set tracking cookie, but we will activate these services only with your consent. If you press the button “Accept”, you consent to the use of these analytics scripts.
You can withdraw your consent at any time. To do so, please modify your configurations on this website by following this link to our privacy statement with the configuration options:
Go to settings
Accept
; Contact Press Room Search About us Research & Development Partnering Jobs and career Media Our unique commitment to pain History Leadership Supervisory Board Responsibility Global presence & sites Products Initiatives & Grants Our positions Grünenthal is a global leader in pain management. Our purpose is to change lives for the better – and innovation is our passion. We’re driven to seek effective, life-changing medicines and solutions for patients with severe diseases and high unmet medical needs.
... About us
... Our unique commitment to pain Although firmly rooted in Germany, today we are very much a growing global Business.
... History Gabriel BaertschiFabian RaschkeMark FladrichJan Adams
A mix of strong entrepreneurial spirit, close collaboration and outstanding performance define our approach to leadership alongside a commitment to diversity and inclusivity.
... Leadership The Supervisory Board advises and controls the Corporate Executive Board and is elected by the shareholders’ summit.
... Supervisory Board ComplianceDisclosure Transfers of ValuesEnvironment, health and safety Social ResponsibilityThalidomide: Our Responsibility Today Responsible Use of Opioids Beyond our overarching purpose – to improve the health of people around the globe – we want to create shared value through sustainability for our company and society as a whole.
... Responsibility Affiliates in EuropeAffiliates in USA & Latin AmericaManufacturing Sites In view of our vision of a world free of pain, Grünenthal strives to provide effective medication to patients worldwide. Therefore, we continuously grow and expand our market presence and product portfolio, and we collaborate with commercial partners and multiple stakeholders from the pain management field and beyond.
... Global presence & sites Patients’ needs are at the heart of everything we do; using our passion for science, we develop long-lasting solutions that directly address these needs.
... Products We are dedicated to creating a better future for our patients, so getting involved with diverse initiatives that support this goal is vital.
... Initiatives & Grants
... Our positions R&D approach Collaboration Pipeline Strategic therapeutic areas Clinical trials Our company has a clear vision of a world free of pain and we maintain a laser-sharp focus on this vision in everything we do – especially in our research and development activities.
... Research & Development Innovation Hubs We follow a holistic and solution-agnostic approach to deliver highly effective pain treatments, building our programmes on a firm foundation of human pathophysiology and solid human target validation.
... R&D approach
... Collaboration
... Pipeline Peripheral Neuropathic PainChronic post-surgical painChronic Low Back PainOsteoarthritis Grünenthal’s therapeutic area strategy is pursuing four key indications: peripheral neuropathic pain, chronic postoperative pain, chronic low back pain, and osteoarthritis.
... Strategic therapeutic areas Clinical trial portalClinical data sharing As a research-based pharmaceutical company, Grünenthal recognizes the importance of publicly registering clinical trials and making information including results available.
... Clinical trials Areas of interest Public Privat Partnerships We believe that success comes from close collaborations founded on a shared vision to develop innovative medicines for patients that suffer from diseases with high unmet needs.
... Partnering We strengthen and develop our core markets Europe, North America, Latin America and Asia through acquisitions, asset deals, in-licensing, commercialization and distribution deals.
... Areas of interest
... Public Privat Partnerships Meet our people We are Grünenthal Ambition is welcome at Grünenthal. Whether you’re a world-class scientist or a talented graduate, together we drive cutting-edge research projects and develop products of the future. Grünenthal offers a culture of opportunity. Join us!
... Jobs and career Corinne Pala Katrin Fleischer From research scientists and high achieving graduates to experts in marketing and production, our open and inclusive culture helps everyone thrive.
... Meet our people A world free of pain. This is our shared vision. To bring it to life, we execute our strategy and work on our company’s culture – everyday, everywhere, every one of us.
... We are Grünenthal Our Stories Press releases Statements Corporate publications Image resources Video resources Explore our media section and access a range of materials relating to our company, people, medicines and medical devices.
... Media Grünenthal is a global leader in pain management and related diseases. Our purpose is to change lives for the better – and innovation is our passion. We are focusing all of our activities and efforts on moving towards our vision of a world free of pain. Explore our recent stories to see what drives us.
... Our Stories 2019201820172016201520142013 In this section you will find both current and archived press releases published from 2013 onwards by Grünenthal GmbH, Germany.
... Press releases
... Statements Journalists are invited to use our corporate publications for their reporting. The list contains business related publication like the company presentation or the code of conduct. .
... Corporate publications Journalists are invited to use images from our library to illustrate their reporting. The library contains company and R&D related pictures.
... Image resources The library contains a set of company footage. Journalists are invited to use the video material to illustrate their reporting.
... Video resources Search Results Search For a world free of pain Grünenthal’s response to
Covid-19, the new coronavirus
Grünenthal considers the outbreak and spread of Covid-19 (known as new coronavirus) to be a serious situation and fully recognises its responsibilities related to safeguarding the well-being and safety of our employees, their families and our communitites. ... See what we're doing
Grünenthal is a global leader in pain management and related diseases. As a science-based, privately-owned pharmaceutical company, we have a long track record of bringing innovative treatments and state-of-the-art technologies to patients worldwide. Our purpose is to change lives for the better – and innovation is our passion. We are focusing all of our activities and efforts on moving towards our vision of a world free of pain. ... Find out more in Grünenthal’s 2019/20 annual reportGrünenthal Stories View All How Artificial Intelligence plays a key role in pharmaceutical R&D Research 13 October 2020 Keeping patients safe Contract Manufacturing, Patients, Supply Chain 01 October 2020 The courage to fail Culture, People, Strategy 15 September 2020 Relentless focus on patients Patients, Access to healthcare, Supply Chain 28 August 2020 A strong track record in Ecuador Latin America, Pain, Contract Manufacturing 29 July 2020 Reaching more patients in need Pain, Access to healthcare, Patients 23 July 2020 Brain Mind and Pain grant 2020/21 Education, Patients, Research 16 July 2020 Disclosure 2020 Collaboration, Sponsoring, Compliance 02 July 2020 Relaunching CHANGE PAIN Pain, Patients, Education 26 June 2020 An award-winning partner Contract Manufacturing, Events, Collaboration 10 June 2020 A thriving hub for pharma Culture, Access to healthcare 28 May 2020 The 2019/20 Grünenthal Report Strategy, Finance, Research 15 May 2020 Making the most of remote working Culture, People 07 May 2020 Certification milestone for Grünenthal’s hormone plant in Chile Contract Manufacturing, Latin America, Women's Health 16 April 2020 Always prioritising patients Latin America, People, Patients 19 March 2020 Boosting external innovation Partnering, Collaboration 06 March 2020 Call for application E-G-G 2020/21 Pain, Research, Science 06 February 2020 Joining forces in San Francisco Partnering, Collaboration 17 January 2020 What we do
As a science-based pharmaceutical company, we bring innovative treatments and state-of-the-art technologies to people living with pain worldwide. ... Learn more about Grünenthal Reaching more patients in need The FDA has approved Qutenza® for the treatment of neuropathic pain associated with diabetic peripheral neuropathy of the feet in adults. Want to know more about the Grünenthal product range? ... Visit Grünenthal Health Pioneering thinkers We’re driven to seek effective, life-changing medicines and solutions for patients with severe diseases and high unmet medical needs. ... Find out more The power of partnerships Success can only be achieved through close collaboration with those who share the same vision. ... Discover more Careers Ready to create a brighter future for our patients?
With us, let your passion and ideas flow and drive innovation to improve our patients’ lives.
... Work with Grünenthal
This website is for all those with an interest in the global business of Grünenthal Initiatives Grünenthal Health CHANGE PAIN® EFIC-Grünenthal Grant Societal Impact of Pain Grünenthal PRO Services Follow us on LInkedIN Follow us on Instagram Follow us on Twitter Contact Reporting side effects Follow us on social Youtube FacebookMemberships https://efpia.eu/ IFPMA Youtube Facebook Grünenthal 2020 © General Terms and Conditions Terms of Use Imprint Privacy Statement Privacy Statement HCP Sitemap
